title: NMDA channel blockers: memantine and amino-aklylcyclohexanes--in vivo characterization.
abstract: The previous overviews provided the basis for better therapeutic efficacy/tolerability of low to moderate affinity NMDA channel blockers. This prediction finds support in in vitro studies comparing protective and plasticity impairing effects (therapeutic vs. side-effect) of memantine and (+)MK-801. In fact it turned out that memantine had a far better therapeutic index. But can it be confirmed in the in vivo situation?
authors.affiliation: Department of Pharmacological Research, Merz+Co, Frankfurt/Main, Federal Republic of Germany.
authors.forename: W
authors.initials: W
authors.lastname: Danysz
authors.forename: C G
authors.initials: CG
authors.lastname: Parsons
authors.forename: G
authors.initials: G
authors.lastname: Quack
mesh_terms: D000818:Animals; D003510:Cyclohexanes / Q000494:pharmacology*; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology*; D008559:Memantine / Q000494:pharmacology*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*
chemical_list: D003510:Cyclohexanes; D018691:Excitatory Amino Acid Antagonists; D016194:Receptors, N-Methyl-D-Aspartate; D008559:Memantine